Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04203745 · ClinicalTrials.gov registry record · NA
Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions
A NA study, sponsored by Candela Corporation.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04203745 is a NA study that has completed, run by Candela Corporation. The registered enrollment target is 26 participants.
The verdict
NCT04203745, a NA study, has completed, sponsored by Candela Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is intended to evaluate the efficacy and safety of a new diode fractional laser for skin resurfacing and treatment of pigmented lesions.
Interventions
- DEVICE Nonablative Fractional Diode Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2021-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04203745
The ClinicalTrials.gov registry entry for NCT04203745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Candela Corporation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nonablative Fractional Diode Laser is the first listed.
NCT04203745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04203745 about?
NCT04203745 is a clinical study titled "Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions". This study is intended to evaluate the efficacy and safety of a new diode fractional laser for skin resurfacing and treatment of pigmented lesions.
What is the current status of trial NCT04203745?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-09-18. Estimated completion is 2021-08-05.
What interventions are being tested in trial NCT04203745?
The interventions under investigation include: Nonablative Fractional Diode Laser (DEVICE).
Who is sponsoring clinical trial NCT04203745?
This trial is sponsored by Candela Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.